SS Innovations International, Inc. (NASDAQ: SSII) announced the successful completion of what it said is the world's longest-distance robotic telesurgery, with a robot-assisted cardiac procedure performed across approximately 12,500 miles (20,000 kilometers) of fiber network distance between Guyana and India using the company's SSi Mantra surgical robotic system. The procedure was conducted remotely by CEO and cardiac surgeon Dr. Sudhir Srivastava from Guyana, while the patient-side robotic system operated in India, functioning with network latency of approximately 290-300 milliseconds.
The company said the achievement surpasses its previous telesurgery distance record of approximately 6,250 miles and further demonstrates the capabilities of the SSi Mantra platform in long-distance surgical applications. The milestone coincided with the launch of Guyana's National Robotic Surgery Program and follows regulatory approval for the SSi Mantra in Guyana. SS Innovations noted that 173 telesurgeries have now been performed using the platform globally, including 22 cardiac telesurgeries, which it said makes SSi Mantra the only surgical robotic system currently used for robotic cardiac telesurgery.
This record-breaking telesurgery highlights the potential for remote surgical expertise to bridge geographic gaps, particularly in regions with limited access to specialized cardiac care. The SSi Mantra system, developed by SS Innovations, aims to make robotic surgery more affordable and accessible worldwide. The company's product range includes the SSi Mantra surgical robotic system and its suite of SSi Mudra surgical instruments, which support various procedures including cardiac surgery. For more information, visit the company's website at https://ssinnovations.com/.
SS Innovations, an American company headquartered in India, plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. The successful telesurgery over such a vast distance underscores the reliability of the SSi Mantra platform and its potential to transform surgical care delivery. As the only surgical robotic system currently used for robotic cardiac telesurgery, SSi Mantra is positioned to lead in this emerging field. The full press release can be viewed at https://ibn.fm/GXylH.
